# OptiNeoCare: optimisation of routine care in the management of severe perinatal asphyxia in full-term or near-term newborns – study protocol for analysis of suboptimal care by confidential inquiries and e-self report

**Authors:** Isabelle Guellec, Pierre-Yves Ancel, Hendy Abdoul, Charles Garabedian, Eric Verspyck, Cyril Huissoud, Marie Delnaud, Blanche Graesslin, Thomas Desplanches, Gilles Cambonie, Pierre Tourneux, Thierry Debillon, Ayoub Mitha, Gauthier Loron, Géraldine Favrais, Maliha Badr, Sophie Chapeliere, Marie Brasseur-Daudruy, Max Gonzalez Estevez, Agnes Rigouzzo, Pierre Delorme, Gilles Kayem

PMC · DOI: 10.1136/bmjopen-2025-106093 · BMJ Open · 2025-07-05

## TL;DR

This study aims to assess how often poor care contributes to severe perinatal asphyxia in newborns and identify ways to improve outcomes through better medical practices.

## Contribution

OptiNeoCare introduces a structured approach to evaluate suboptimal care in asphyxia cases using confidential inquiries and electronic self-reports.

## Key findings

- Up to 50% of asphyxia cases may involve suboptimal care, according to previous audits.
- The study will use root cause analysis to identify determinants of poor care.
- Findings will be compared between morbi-mortality reviews and confidential expert inquiries.

## Abstract

Severe perinatal asphyxia at term or near term remains a critical public health issue, associated with high risks of neonatal death and hypoxic-ischaemic encephalopathy (HIE). Despite improved clinical guidelines, suboptimal care persists in many cases, and previous audits have demonstrated that up to 50% of asphyxia cases could be associated with suboptimal care. OptiNeoCare is a French study which aims to assess the prevalence and determinants of suboptimal obstetric and neonatal care and evaluate its potential impact on neonatal outcomes.

This prospective, population-based observational study will include newborns ≥36 weeks’ gestation with severe perinatal asphyxia across 12 French perinatal networks (213 maternity units). Inclusion criteria comprise neonatal death or moderate/severe HIE with confirmed biochemical markers of asphyxia. Data will be collected prospectively from labour wards, transport teams and neonatal intensive care units using an electronic case report form, and the in-situ team will be invited to complete a morbi-mortality review (MMR). Approximately 336 cases will be included over 12 months, with 25% randomly selected for confidential enquiry by two experts. The quality of care will be assessed based on a structured classification of medical errors (diagnostic, therapeutic, preventive and systemic) by a panel of experts including an obstetrician or midwife and a paediatrician. Root cause analysis will identify determinants of suboptimal care. A concordance analysis will compare findings from MMRs and confidential enquiries. Statistical analysis will include multivariable logistic regression to explore associations between care quality and neonatal outcomes.

Ethical approval was granted by the Ethics Committee for Research in Obstetrics and Gynaecology. Informed non-opposition is required from participants. Results will be shared with participating centres, healthcare professionals and through scientific dissemination.

ClinicalTrials.gov ID: NCT06322732.

## Full-text entities

- **Diseases:** neonatal death (MESH:D066087), HIE (MESH:D002534), asphyxia (MESH:D001237)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12228471/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12228471/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12228471/full.md

---
Source: https://tomesphere.com/paper/PMC12228471